Ex Vivo Identification of IDH Mutant Gliomas Using Edited Magnetic Resonance Spectroscopy Detection of 2HG at 9.4 Tesla

Ex Vivo Infiltrative Brain Tumor Histologically Correlates with Decreased ADC and Increased RCBV as Measured with Functional Diffusion and Perfusion Maps

11C-Methionine PET Parametric Response Map, But Not Conventional MRI, Corresponds to Treatment Response of WT1 Immunotherapy for Recurrent Malignant Glioma.

2-Hydroxyglutarate in Gliomas with IDH Gene Mutation Using High Resolution 1H-NMR Spectroscopy of Tissue Extracts

Analysis of 1H MRSI Data of Brain Tumours Using LCModel and Whole Tissue Representations